HIF1α, as well as phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/Akt/mTOR) pathways are crucial regulators of cancer cell proliferation and glycolytic metabolism [49]. This evidence concerns the gene AKT1 and cancer.